시스타틴 C 측정 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품별, 방법별, 검체 유형별, 용도별, 지역별, 경쟁별(2020-2030년)

The Global Cystatin C Assay Market, valued at USD 385.54 Million in 2024, is projected to experience a CAGR of 6.18% to reach USD 552.49 Million by 2030. A Cystatin C assay is an in vitro diagnostic test that quantitatively measures Cystatin C levels in biological fluids, primarily serum or plasma, serving as a reliable biomarker for assessing renal function and estimating glomerular filtration rate (GFR). This assay is increasingly utilized due to its advantages over creatinine-based tests, as Cystatin C levels are less influenced by factors such as muscle mass, age, or sex.

Key Market Drivers

The market for Cystatin C assays is significantly propelled by the recognized superiority of Cystatin C as an early and accurate renal biomarker. This protein offers a more reliable and precise assessment of glomerular filtration rate because its levels are largely independent of confounding factors such as muscle mass, age, sex, and diet, which often influence creatinine measurements. This intrinsic biological advantage positions Cystatin C as a preferred biomarker for detecting subtle changes in kidney function and facilitating earlier diagnosis. For instance, according to a study published in the Journal of Clinical and Diagnostic Research on March 1, 2024, regression analysis indicated a tighter distribution of results for cystatin C, with an R2 value of 0.67, compared to 0.64 for creatinine, demonstrating its superior predictive ability for GFR.

Key Market Challenges

The elevated cost of Cystatin C reagents and associated testing presents a significant challenge to the widespread growth of the Global Cystatin C Assay Market. This comparative expense, particularly when benchmarked against established and more affordable creatinine assays, directly influences procurement decisions within diverse healthcare systems. The financial disparity strains operational budgets for clinical laboratories, making the adoption of these advanced diagnostics a subject of intense scrutiny regarding cost-effectiveness. Consequently, despite the recognized clinical benefits of Cystatin C assays for more precise renal function assessment, their higher cost hinders broader integration into routine diagnostic panels.

Key Market Trends

The growing demand for automated assay systems represents a significant market trend, driven by the need for enhanced efficiency, reduced manual errors, and increased throughput in clinical laboratories. Automation streamlines complex workflows, from sample handling to result analysis, which is critical for managing high testing volumes and addressing staffing shortages. For instance, the College of American Pathologists, in its 2024 Surveys and Anatomic Pathology Education Programs document, highlighted that it offers more than 700 proficiency testing programs, reflecting the extensive scope of quality assurance in laboratory diagnostics that benefits from automated processes.

Key Market Players

• F. Hoffmann-La Roche Ltd
• Abbott Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Siemens Healthineers AG
• Bio-Techne
• Agilent Technologies, Inc
• Gentian Diagnostics ASA
• Abcam Limited
• Getein Biotech, Inc
• Sino Biological, Inc

Report Scope:

In this report, the Global Cystatin C Assay Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cystatin C Assay Market, By Product:

• Analyzers
• Kits
• Reagents

Cystatin C Assay Market, By Method:

• Enzyme-Linked Immunosorbent Assay (ELISA)
• Particle-Enhanced Turbidimetric Immunoassay (PETIA)
• Particle-enhanced Nephelometric Immunoassay (PENIA)
• Chemiluminescent immunoassay (CLIA)
• Immunofluorescence assay (IFA)
• Others

Cystatin C Assay Market, By Sample Type:

• Blood
• Urine

Cystatin C Assay Market, By Application:

• Diagnostics
• Research

Cystatin C Assay Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Cystatin C Assay Market.

Available Customizations:

Global Cystatin C Assay Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cystatin C Assay Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Analyzers, Kits, Reagents)
  • 5.2.2. By Method (Enzyme-Linked Immunosorbent Assay (ELISA), Particle-Enhanced Turbidimetric Immunoassay (PETIA), Particle-enhanced Nephelometric Immunoassay (PENIA), Chemiluminescent immunoassay (CLIA), Immunofluorescence assay (IFA), Others)
  • 5.2.3. By Sample Type (Blood, Urine)
  • 5.2.4. By Application (Diagnostics, Research)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Cystatin C Assay Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Method
  • 6.2.3. By Sample Type
  • 6.2.4. By Application
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cystatin C Assay Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Method
      • 6.3.1.2.3. By Sample Type
      • 6.3.1.2.4. By Application
  • 6.3.2. Canada Cystatin C Assay Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Method
      • 6.3.2.2.3. By Sample Type
      • 6.3.2.2.4. By Application
  • 6.3.3. Mexico Cystatin C Assay Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Method
      • 6.3.3.2.3. By Sample Type
      • 6.3.3.2.4. By Application

7. Europe Cystatin C Assay Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Method
  • 7.2.3. By Sample Type
  • 7.2.4. By Application
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Cystatin C Assay Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Method
      • 7.3.1.2.3. By Sample Type
      • 7.3.1.2.4. By Application
  • 7.3.2. France Cystatin C Assay Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Method
      • 7.3.2.2.3. By Sample Type
      • 7.3.2.2.4. By Application
  • 7.3.3. United Kingdom Cystatin C Assay Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Method
      • 7.3.3.2.3. By Sample Type
      • 7.3.3.2.4. By Application
  • 7.3.4. Italy Cystatin C Assay Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Method
      • 7.3.4.2.3. By Sample Type
      • 7.3.4.2.4. By Application
  • 7.3.5. Spain Cystatin C Assay Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Method
      • 7.3.5.2.3. By Sample Type
      • 7.3.5.2.4. By Application

8. Asia Pacific Cystatin C Assay Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Method
  • 8.2.3. By Sample Type
  • 8.2.4. By Application
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Cystatin C Assay Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Method
      • 8.3.1.2.3. By Sample Type
      • 8.3.1.2.4. By Application
  • 8.3.2. India Cystatin C Assay Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Method
      • 8.3.2.2.3. By Sample Type
      • 8.3.2.2.4. By Application
  • 8.3.3. Japan Cystatin C Assay Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Method
      • 8.3.3.2.3. By Sample Type
      • 8.3.3.2.4. By Application
  • 8.3.4. South Korea Cystatin C Assay Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Method
      • 8.3.4.2.3. By Sample Type
      • 8.3.4.2.4. By Application
  • 8.3.5. Australia Cystatin C Assay Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Method
      • 8.3.5.2.3. By Sample Type
      • 8.3.5.2.4. By Application

9. Middle East & Africa Cystatin C Assay Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Method
  • 9.2.3. By Sample Type
  • 9.2.4. By Application
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Cystatin C Assay Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Method
      • 9.3.1.2.3. By Sample Type
      • 9.3.1.2.4. By Application
  • 9.3.2. UAE Cystatin C Assay Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Method
      • 9.3.2.2.3. By Sample Type
      • 9.3.2.2.4. By Application
  • 9.3.3. South Africa Cystatin C Assay Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Method
      • 9.3.3.2.3. By Sample Type
      • 9.3.3.2.4. By Application

10. South America Cystatin C Assay Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Method
  • 10.2.3. By Sample Type
  • 10.2.4. By Application
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Cystatin C Assay Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Method
      • 10.3.1.2.3. By Sample Type
      • 10.3.1.2.4. By Application
  • 10.3.2. Colombia Cystatin C Assay Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Method
      • 10.3.2.2.3. By Sample Type
      • 10.3.2.2.4. By Application
  • 10.3.3. Argentina Cystatin C Assay Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Method
      • 10.3.3.2.3. By Sample Type
      • 10.3.3.2.4. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Cystatin C Assay Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. F. Hoffmann-La Roche Ltd
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Abbott Laboratories Inc.
• 15.3. Thermo Fisher Scientific Inc.
• 15.4. Siemens Healthineers AG
• 15.5. Bio-Techne
• 15.6. Agilent Technologies, Inc
• 15.7. Gentian Diagnostics ASA
• 15.8. Abcam Limited
• 15.9. Getein Biotech, Inc
• 15.10. Sino Biological, Inc

16. Strategic Recommendations

17. About Us & Disclaimer